Frederik Desmarais

Mr. Frederik Desmarais

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
SDSteven M. Dragos
Steven M. Dragos
KBKarl-Frederik Bergeron
Karl-Frederik Bergeron
FDFrederik Desmarais
Frederik Desmarais
KSKatherine Suitor
Katherine Suitor
DWDavid C. Wright
David C. Wright
DMDavid Mutch
David Mutch
White adipose tissue (WAT) has a critical role in lipid handling. Previous work demonstrated that SCD1 is an important regulator of WAT fatty acid (FA) composition; however, its influence on the various interconnected pathways influencing WAT lipid handling remains unclear. Our objective was to investigate the role of SCD1 on WAT lipid handling using Scd1 knockout (KO) mice and SCD1-inhibited 3T3-L1 adipocytes by measuring gene, protein, and metabolite markers related to FA reesterification, glyceroneogenesis, and lipolysis. Triacylglycerol (TAG) content was higher in inguinal WAT (iWAT) from KO mice compared with wild-type, but significantly lower in epididymal WAT (eWAT). The SCD1 desaturation index was decreased in both WAT depots in KO mice. FA reesterification, as measured with a NEFA:glycerol ratio, was reduced in both WAT depots in KO mice, as well as SCD1-inhibited 3T3-L1 adipocytes. Pck1, Atgl, and Hsl gene expression was reduced in both WAT depots of KO mice, while Pck2 and Pdk4 gene expression showed depot-specific regulation. Pck1, Atgl, and Hsl gene expression was reduced, and phosphoenolpyruvate carboxykinase protein content was ablated, in SCD1-inhibited adipocytes. Our data provide evidence that SCD1 has a broad impact on WAT lipid handling by altering TAG composition in a depot-specific manner, reducing FA reesterification, and regulating markers of lipolysis and glyceroneogenesis.

4 June 2018 in Endocrine
Verified
Journal Article
Closed access
PDF file
FDFrederik Desmarais
Frederik Desmarais
KBKarl-Frederik Bergeron
Karl-Frederik Bergeron
MLMichel Lacaille
Michel Lacaille
ILIsabelle Lemieux
Isabelle Lemieux
JBJean Bergeron
Jean Bergeron
Catherine MounierCatherine Mounier
Catherine Mounier

1 April 2019 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
FDFrederik Desmarais
Frederik Desmarais
KBKarl-Frederik Bergeron
Karl-Frederik Bergeron
EREric Rassart
Eric Rassart
Catherine MounierCatherine Mounier
Catherine Mounier

Verified
Journal Article
Open access
PDF file
FDFrederik Desmarais
Frederik Desmarais
VHVincent Hervé
Vincent Hervé
KBKarl-Frederik Bergeron
Karl-Frederik Bergeron
GRGaétan Ravaut
Gaétan Ravaut
MPMorgane Perrotte
Morgane Perrotte
Catherine MounierCatherine Mounier
Catherine Mounier
Apolipoprotein D (ApoD) is a secreted lipocalin associated with neuroprotection and lipid metabolism. In rodent, the bulk of its expression occurs in the central nervous system. Despite this, ApoD has profound effects in peripheral tissues, indicating that neural ApoD may reach peripheral organs. We endeavor to determine if cerebral ApoD can reach the circulation and accumulate in peripheral tissues. Three hours was necessary for over 40% of all the radiolabeled human ApoD (hApoD), injected bilaterally, to exit the central nervous system (CNS). Once in circulation, hApoD accumulates mostly in the kidneys/urine, liver, and muscles. Accumulation specificity of hApoD in these tissues was strongly correlated with the expression of lowly glycosylated basigin (BSG, CD147). hApoD was observed to pass through bEnd.3 blood brain barrier endothelial cells monolayers. However, cyclophilin A did not impact hApoD internalization rates in bEnd.3, indicating that ApoD exit from the brain is either independent of BSG or relies on additional cell types. Overall, our data showed that ApoD can quickly and efficiently exit the CNS and reach the liver and kidneys/urine, organs linked to the recycling and excretion of lipids and toxins. This indicated that cerebral overexpression during neurodegenerative episodes may serve to evacuate neurotoxic ApoD ligands from the CNS.